27
Sep
2007
Celgene Makes Ya Go Hmmm…
Posted in CO Private: GlobeImmune, CO Pub Rel: Celgene, CO Public: Array, CO Public: Pharmion
Just what I think to be an interesting observation…that is how deep New Jersey-based Celgene (NASDAQ: CELG) has penetrated into the Colorado bio-scape. The connection appears to have initiated back in 2001 on a licensing deal with Pharmion (NASDAQ: PHRM) for Thalomid® (BTW…take a listen to Pharmion’s UBS Global Life Sciences Conference presentation from today [...]
27
Sep
2007
New FBBp Home on the Web!
Posted in FBBp
Fitzsimons BioBusiness Partners, Inc. (FBBp) has launched a new website (here). Please take a look at the information booklet. If you are working with or contemplating a start-up in the therapeutic, diagnostic, vaccine, device or bioinformatics space FBBp may function to accelerate what you have cooking in the lab towards commercialization. You may also observe [...]
26
Sep
2007
GlobeImmune, Inc. closed a $41.2MM Series C financing. The round was led by Wexford Capital, other participants include Celgene (NASDAQ: CELG), Mellon Family Investment Company, Richard King Mellon Foundation, Eminent Venture Capital Corp., Boston Life Science Venture, and WRF Capital. Previous investors who participated in the round include HealthCare Ventures, Morgenthaler Ventures, Sequel Venture Partners, [...]
26
Sep
2007
Congratulations to Dr. Dan Stinchcomb, President & CEO and the entire team at InViragen (Ft. Collins) on their new partnership with the Pediatric Dengue Vaccine Initiative, to help develop and manufacture a dengue vaccine to be made widely available for the global prevention of dengue fever, the second most prevalent tropical disease after malaria. Dengue [...]
25
Sep
2007
Replidyne, Inc. (NASDAQ: RDYN) was featured in the 24 September issue of BioCentury, The Bernstein Report on BioBusiness! The article features some of the companies earlier stage pipeline, particularly REP3123 a MetRS inhibitor in preclinical development that may be more effective for severe Clostridium difficile-associated diarrhea (CDAD) than ViroPharma (NASDAQ: VPHM) and Eli Lilly’s (NYSE: [...]
24
Sep
2007
Array BioPharma, Inc. (NASDAQ: ARRY) and Celgene Corp. (NASDAQ: CELG) announced a worldwide strategic collaboration focused on the discovery, development and commercialization of novel therapeutics in cancer and inflammation. Celgene will make an upfront payment of $40MM to Array, in return Array will grant Celgene an option to select drugs developed under the collaboration that [...]
23
Sep
2007
Venture Showcase Deadline 5 October!
Posted in Events
The BioWest Venture Showcase provides an incredible opportunity for regional and national exposure…so don’t miss the application deadline of 5 October! Six companies will be chosen to present at this year’s Showcase (December 6 & 7 at the Grand Hyatt, Denver, CO) to be judged by a distinguished panel of national venture capitalists. The winning [...]
17
Sep
2007
14
Sep
2007
Now That is Giving Back!
Posted in People
(Amgen logo circa 1983)Thanks to my biobeer buddies who beat me to the punch on this not so small tidbit. Dr. Marvin H. Caruthers professor in the department of Chemistry and Biochemistry at the University of Colorado donated a whopping $20MM to be allocated towards the construction of the $115MM Systems Biotechnology Building which will [...]
12
Sep
2007
Colorado Public Company News:
Posted in CO Public: Accelr8, CO Public: Allos Therapeutics, CO Public: Array, CO Public: Aspen BioPharma, CO Public: Ceragenix Pharma, CO Public: Encision, CO Public: Heska, CO Public: Tapestry Pharma
By my calculations there are ten publicly traded CO-based life science companies. I will begin a regular update of this group. Another group of public companies are operating in or have other significant interests or relationships with entities in Colorado. This group includes Amgen (NASDAQ: AMGN), Gilead (NASDAQ: GILD), Merck (NYSE: MRK), Roche (VTX: ROG.VX) [...]
10
Sep
2007
Finishing off Michael West’s (founder of Geron NASDAQ: GERN and Advanced Cell Technology OTCBB: ACTC.OB) The Immortal Cell (TIC) left me with a lingering thought…my geophysical and other biases aside…Colorado truly is an amazing place, and without a doubt has been (since Keith Porter’s arrival) and continues to remain at the forefront of innovation from [...]
08
Sep
2007
3 Commercialized Products & Counting!
Posted in CO Pub Rel: Amgen, CO Pub Rel: Merck, CO Pub Rel: OSI Pharma
QUESTION: What do ZostaVax®, Kineret® and Macugen® have in common… ANSWER: They are all FDA approved first-in-class commercialized products originating from University of Colorado intellectual property. Want to learn more about these products and the rich product pipeline portfolio at the University of Colorado? Then take a listen to this podcast featuring David Allen, Ph.D., [...]
05
Sep
2007
If you were unable to make it to the wonderful Colorado Medical Device Symposium on 22 August, not to worry, it can come to you now via podcast. Here is the first session moderated by the very talented Mr. Andrew Gano, MBA, licensing associate with the University Colorado Technology Transfer Office. Andrew not only orchestrated [...]
Life Science Deal Flow PARTNERS
-
